Clinical Trials Browser

Phase 2/3 × pertuzumab × Gastrointestinal × Clear all

Urinary Bladder Neoplasms, Gallbladder Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT02581462 2020-08-11

PETRARCA

Phase 2/3 Completed

81 enrolled

Gastrointestinal

Stomach Neoplasms

Clinical Trials

DETERMINE

PETRARCA